Lumos Pharma Inc (NASDAQ:LUMO)
| 15.70 Delayed Data As of Dec 02 |  -0.13 / -0.84%Today’s Change | 6.74 Today|||52-Week Range 32.40 | -31.05% Year-to-Date |
Latest LUMO News | Press Releases
No recent news for Lumos Pharma Inc.
Today’s Trading
| Previous close | 15.51 |
| Today’s open | 15.57 |
| Day’s range | 15.07 - 15.69 |
| Volume | 6,721 |
| Average volume (3 months) | 19,746 |
| Market cap | $124.4M |
Data as of 11:41am ET, 12/02/2020
Growth & Valuation
| Earnings growth (last year) | +20.01% |
| Earnings growth (this year) | +85.46% |
| Earnings growth (next 5 years) | +15.24% |
| Revenue growth (last year) | -92.50% |
| P/E ratio | NM |
| Price/Sales | 100.81 |
| Price/Book | 0.77 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LQDALiquidia Corp | 0.00 | 0.00% |
| TCONTRACON Pharmaceutica... | +0.27 | +2.97% |
| KZIAKazia Therapeutics L... | +0.17 | +1.72% |
| AGTCApplied Genetic Tech... | +0.18 | +3.73% |
Data as of 3:59pm ET, 12/02/2020
Financials
| Next reporting date | March 4, 2021 |
| EPS forecast (this quarter) | -$0.86 |
| Annual revenue (last year) | $936.0K |
| Annual profit (last year) | -$43.0M |
| Net profit margin | -4,592.84% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Austin, Texas |
Forecasts
